Viewing Study NCT01716234


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2025-12-30 @ 6:17 PM
Study NCT ID: NCT01716234
Status: TERMINATED
Last Update Posted: 2018-08-27
First Post: 2012-10-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-04-17
Start Date Type: ACTUAL
Primary Completion Date: 2015-04-01
Primary Completion Date Type: ACTUAL
Completion Date: 2015-04-01
Completion Date Type: ACTUAL
First Submit Date: 2012-10-25
First Submit QC Date: None
Study First Post Date: 2012-10-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-03-15
Results First Submit QC Date: None
Results First Post Date: 2016-04-15
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-07-27
Last Update Post Date: 2018-08-27
Last Update Post Date Type: ACTUAL